To further explore the clinical value of BCYRN1 in GC patients, we estimated the association between BCYRN1 expression and clinicopathological characteristics, and found that BCYRN1 expression was closely correlated with tumor depth, lymph node metastasis and clinical stage in patients with GC. The gene discussed is BCYRN1; the disease is neoplasm.